Our study demonstrated that the expression rate of p53 was 48% in sarcomatoid cells, which is higher than that in carcinoma cells, suggesting that p53 might be involved in triggering the development of high malignant sarcomatoid tumors from renal cell carcinoma. Here, TP53 is linked to carcinoma.